Dorothy McCabe, PhD, Discusses How to Combat Biosimilar Misinformation

Season 3, Episode 16,  Aug 02, 2020, 11:00 AM

We sat down with an author of the opinion piece, Dorothy McCabe, PhD, the executive director of clinical development and medical affairs, immunology and biosimilars at Boehringer Ingelheim Pharmaceuticals and co-chair of the Biosimilars Forum education committee, to discuss what more needs to be done to combat biosimilar misinformation and how patients and physicians can help the cause.

To learn more about the opinion piece McCabe co-authored, click here.
To learn more about Boehringer Ingelheim, visit boehringer-ingelheim.com.